The hedge fund’s shares of CHS are valued at $496,037. CHS makes up about 0.22 percent of Palouse Capital’s portfolio, according to Founders Daily.
Other hedge funds, including Dupont Capital Management, also reduced their stakes in CHS in the most recent quarter.
More articles on healthcare finance:
Fitch: Clinton’s healthcare plan could benefit hospitals in the near term, but long-term effects uncertain
CMS makes offer to clear Medicare appeals backlog: 6 things to know
UPMC operating margin shrinks in Q1
Register to Attend Webinar
Presenters:
Kyle Snider, MemorialCare|Michael Hopkins, Northwestern Memorial Hospital|Dameka Miller, Trinity Health|Ginger Sharp, Legacy Health|Kellan Tittle, MBA, People Incorporated Mental Health Services
Next Up in Financial Management
-
Providence, R.I.-based Brown University Health has eliminated or consolidated 10 senior leadership positions and is offering a voluntary separation program…
-
When Kathy Donovan joined Springfield, Ill.-based Hospital Sisters Health System as senior vice president and chief operating officer in 2023,…
-
Keith Mueller, PhD, director of RUPRI at the University of Iowa in Iowa City, and a founding member of its…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
